BACKGROUND: Seroadaptive behaviors among men who have sex with men (MSM) are common, but ascertaining behavioral information is challenging in clinical settings. To address this, we developed a single seroadaptive behavior question. METHODS: Men who have sex with men 18 years or older attending a sexually transmitted disease clinic in Seattle, WA, from 2013 to 2015, were eligible for this cross-sectional study. Respondents completed a comprehensive seroadaptive behavior questionnaire which included a single question that asked HIV-negative MSM to indicate which of 12 strategies they used in the past year to reduce their HIV risk. HIV testing was performed per routine clinical care. We used the κ statistic to examine agreement between the comprehensive questionnaire and the single question. RESULTS: We enrolled HIV-negative MSM at 3341 (55%) of 6105 eligible visits. The agreement between the full questionnaire and single question for 5 behaviors was fair to moderate (κ values of 0.34-0.59). From the single question, the most commonly reported behaviors were as follows: avoiding sex with HIV-positive (66%) or unknown-status (52%) men and using condoms with unknown-status partners (53%); 8% of men reported no seroadaptive behavior. Men tested newly HIV positive at 38 (1.4%) of 2741 visits. HIV test positivity for the most commonly reported behaviors ranged from 0.8% to 1.3%. Men reporting no seroadaptive strategy had a significantly higher HIV test positivity (3.5%) compared with men who reported at least 1 strategy (1.3%; P = 0.02). CONCLUSIONS: The single question performed relatively well against a comprehensive seroadaptive behaviors assessment and may be useful in clinical settings to identify men at greatest risk for HIV.
BACKGROUND: Seroadaptive behaviors among men who have sex with men (MSM) are common, but ascertaining behavioral information is challenging in clinical settings. To address this, we developed a single seroadaptive behavior question. METHODS:Men who have sex with men 18 years or older attending a sexually transmitted disease clinic in Seattle, WA, from 2013 to 2015, were eligible for this cross-sectional study. Respondents completed a comprehensive seroadaptive behavior questionnaire which included a single question that asked HIV-negative MSM to indicate which of 12 strategies they used in the past year to reduce their HIV risk. HIV testing was performed per routine clinical care. We used the κ statistic to examine agreement between the comprehensive questionnaire and the single question. RESULTS: We enrolled HIV-negative MSM at 3341 (55%) of 6105 eligible visits. The agreement between the full questionnaire and single question for 5 behaviors was fair to moderate (κ values of 0.34-0.59). From the single question, the most commonly reported behaviors were as follows: avoiding sex with HIV-positive (66%) or unknown-status (52%) men and using condoms with unknown-status partners (53%); 8% of men reported no seroadaptive behavior. Men tested newly HIV positive at 38 (1.4%) of 2741 visits. HIV test positivity for the most commonly reported behaviors ranged from 0.8% to 1.3%. Men reporting no seroadaptive strategy had a significantly higher HIV test positivity (3.5%) compared with men who reported at least 1 strategy (1.3%; P = 0.02). CONCLUSIONS: The single question performed relatively well against a comprehensive seroadaptive behaviors assessment and may be useful in clinical settings to identify men at greatest risk for HIV.
Authors: Paul Bogowicz; David Moore; Steve Kanters; Warren Michelow; Wayne Robert; Robert Hogg; Réka Gustafson; Mark Gilbert Journal: Int J STD AIDS Date: 2015-03-02 Impact factor: 1.359
Authors: Fengyi Jin; June Crawford; Garrett P Prestage; Iryna Zablotska; John Imrie; Susan C Kippax; John M Kaldor; Andrew E Grulich Journal: AIDS Date: 2009-01-14 Impact factor: 4.177
Authors: Snigdha Vallabhaneni; Xin Li; Eric Vittinghoff; Deborah Donnell; Christopher D Pilcher; Susan P Buchbinder Journal: PLoS One Date: 2012-10-03 Impact factor: 3.240
Authors: Risha Irvin; Snigdha Vallabhaneni; Hyman Scott; John K Williams; Leo Wilton; Xin Li; Susan Buchbinder Journal: PLoS One Date: 2015-02-17 Impact factor: 3.240
Authors: Eli Samuel Rosenberg; Jeremy Alexander Grey; Travis Howard Sanchez; Patrick Sean Sullivan Journal: JMIR Public Health Surveill Date: 2016-05-17
Authors: Christine M Khosropour; Julia C Dombrowski; Fred Swanson; Roxanne P Kerani; David A Katz; Lindley A Barbee; James P Hughes; Lisa E Manhart; Matthew R Golden Journal: J Acquir Immune Defic Syndr Date: 2016-06-01 Impact factor: 3.731
Authors: Christine M Khosropour; Julia C Dombrowski; Lindley A Barbee; Roxanne P Kerani; Anna Berzkalns; Matthew R Golden Journal: J Acquir Immune Defic Syndr Date: 2021-08-01 Impact factor: 3.771
Authors: Laura M Mann; Colleen F Kelley; Aaron J Siegler; Rob Stephenson; Patrick S Sullivan Journal: J Acquir Immune Defic Syndr Date: 2022-01-01 Impact factor: 3.771